Limitations, agreements, and source contact

GVAX vs. Placebo for MDS/AML After Allo HSCT · Source last updated 2022-07-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

point Of Contact

email

Vincent_Ho@dfci.harvard.edu

organization

Dana-Farber Cancer Institute

phone

617-632-5938

title

Dr. Vincent Ho

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice